Article info
Research Article
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade
- ↵a frederick.kohlhapp{at}rutgers.edu
- ↵b joebroucek{at}gmail.com
- ↵c Tasha_Hughes{at}rush.edu
- ↵d erica.j.huelsmann{at}gmail.com
- ↵e j.lusciks{at}gmail.com
- ↵f janetzayas01{at}gmail.com
- ↵g hdolubizno{at}gmail.com
- ↵h vidyaratna_a_fleetwood{at}rush.edu
- ↵i yo.alisagrin{at}gmail.com
- ↵j graham.hilldo{at}gmail.com
- ↵k josephposhepny{at}gmail.com
- ↵l nabatiyan{at}gmail.com
- ↵m carl.ruby{at}yahoo.com
- ↵n snook5029{at}gmail.com
- ↵o jarudra{at}UTMB.EDU
- ↵p jasonschenkel2007{at}u.northwestern.edu
- ↵q masopust{at}umn.edu
- ↵r andrew.zloza{at}rutgers.edu
- ↵s howard.kaufman{at}rutgers.edu
Citation
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade
Publication history
- Received March 9, 2015
- Accepted April 17, 2015
- First published May 19, 2015.
Online issue publication
February 16, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s). 2015